APO Research
Talk to an analyst

APO RESEARCH · REPORT

Jet Lag Treatment

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.

The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.

In our report, the measurement level is unit, which means that each unit is the same as each pill.

Selected research

Market Outlook & Growth Opportunities

Global Jet Lag Treatment Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchJet Lag Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Jet Lag Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Jet Lag Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Jet Lag Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Jet Lag Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.

The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.

In our report, the measurement level is unit, which means that each unit is the same as each pill.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.The key manufacturers are Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma etc. Top 3 companies occupied about 22% market share.

This report provides an overview of the global Jet Lag Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Jet Lag Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Jet Lag Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Jet Lag Treatment market.

Jet Lag Treatment Segment by Company

Teva

Mylan

Nature’s Bounty

Otsuka Pharma (Pharmavite)

Boiron

Miers Laboratories

Genexa

Homeocan

Clinigen Group

Vanda Pharma

Jet Lag Treatment Segment by Type

Prescription

OTC

Jet Lag Treatment Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online

Jet Lag Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Jet Lag Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Jet Lag Treatment key companies, revenue, market share, and recent developments.

3. To split the Jet Lag Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Jet Lag Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Jet Lag Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Jet Lag Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Jet Lag Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Jet Lag Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Jet Lag Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Jet Lag Treatment industry.

Chapter 3: Detailed analysis of Jet Lag Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Jet Lag Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Jet Lag Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Jet Lag Treatment Industry Trends Table 2. Jet Lag Treatment Industry Drivers Table 3. Jet Lag Treatment Industry Opportunities and Challenges Table 4. Jet Lag Treatment Industry Restraints Table 5. Global Jet Lag Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Jet Lag Treatment Revenue Share by Company (2021-2026) Table 7. Global Jet Lag Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Jet Lag Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Jet Lag Treatment Company, Product Type & Application Table 10. Global Jet Lag Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Jet Lag Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prescription Table 15. Significant Companies of OTC Table 16. Global Jet Lag Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Jet Lag Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Jet Lag Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Jet Lag Treatment Sales Value Share by Type (2021-2026) Table 20. Global Jet Lag Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Pharmacies Table 22. Significant Companies of Retail Pharmacies Table 23. Significant Companies of Online Table 24. Global Jet Lag Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Jet Lag Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Jet Lag Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Jet Lag Treatment Sales Value Share by Application (2021-2026) Table 28. Global Jet Lag Treatment Sales Value Share by Application (2027-2032) Table 29. Global Jet Lag Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Jet Lag Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Jet Lag Treatment Sales Value Share by Region (2021-2026) Table 32. Global Jet Lag Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Jet Lag Treatment Sales Value Share by Region (2027-2032) Table 34. Global Jet Lag Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Jet Lag Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Jet Lag Treatment Sales Value Market Share by Country (2021-2026) Table 37. Global Jet Lag Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Jet Lag Treatment Sales Value Market Share by Country (2027-2032) Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Teva Jet Lag Treatment Product Portfolio Table 43. Teva Recent Development Table 44. Mylan Company Information Table 45. Mylan Business Overview Table 46. Mylan Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Mylan Jet Lag Treatment Product Portfolio Table 48. Mylan Recent Development Table 49. Nature’s Bounty Company Information Table 50. Nature’s Bounty Business Overview Table 51. Nature’s Bounty Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Nature’s Bounty Jet Lag Treatment Product Portfolio Table 53. Nature’s Bounty Recent Development Table 54. Otsuka Pharma (Pharmavite) Company Information Table 55. Otsuka Pharma (Pharmavite) Business Overview Table 56. Otsuka Pharma (Pharmavite) Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Otsuka Pharma (Pharmavite) Jet Lag Treatment Product Portfolio Table 58. Otsuka Pharma (Pharmavite) Recent Development Table 59. Boiron Company Information Table 60. Boiron Business Overview Table 61. Boiron Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Boiron Jet Lag Treatment Product Portfolio Table 63. Boiron Recent Development Table 64. Miers Laboratories Company Information Table 65. Miers Laboratories Business Overview Table 66. Miers Laboratories Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Miers Laboratories Jet Lag Treatment Product Portfolio Table 68. Miers Laboratories Recent Development Table 69. Genexa Company Information Table 70. Genexa Business Overview Table 71. Genexa Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Genexa Jet Lag Treatment Product Portfolio Table 73. Genexa Recent Development Table 74. Homeocan Company Information Table 75. Homeocan Business Overview Table 76. Homeocan Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Homeocan Jet Lag Treatment Product Portfolio Table 78. Homeocan Recent Development Table 79. Clinigen Group Company Information Table 80. Clinigen Group Business Overview Table 81. Clinigen Group Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Clinigen Group Jet Lag Treatment Product Portfolio Table 83. Clinigen Group Recent Development Table 84. Vanda Pharma Company Information Table 85. Vanda Pharma Business Overview Table 86. Vanda Pharma Jet Lag Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Vanda Pharma Jet Lag Treatment Product Portfolio Table 88. Vanda Pharma Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Jet Lag Treatment Product Image Figure 2. Global Jet Lag Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Jet Lag Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Jet Lag Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prescription Image Figure 8. OTC Image Figure 9. Global Jet Lag Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Jet Lag Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Jet Lag Treatment Sales Value Share by Type (2021-2032) Figure 12. Hospital Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Online Image Figure 15. Global Jet Lag Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Jet Lag Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Jet Lag Treatment Sales Value Share by Application (2021-2032) Figure 18. Global Jet Lag Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Jet Lag Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Jet Lag Treatment Sales Value (2021-2032) & (US$ Million) Figure 21. North America Jet Lag Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Jet Lag Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Jet Lag Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Jet Lag Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Jet Lag Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Jet Lag Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. South America Jet Lag Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Jet Lag Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Jet Lag Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Jet Lag Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription
  • OTC
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
Companies covered
  • Teva
  • Mylan
  • Nature’s Bounty
  • Otsuka Pharma (Pharmavite)
  • Boiron
  • Miers Laboratories
  • Genexa
  • Homeocan
  • Clinigen Group
  • Vanda Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Jet Lag Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Jet Lag Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Jet Lag Treatment Market Dynamics
  1. 2.1 Jet Lag Treatment Industry Trends
  2. 2.2 Jet Lag Treatment Industry Drivers
  3. 2.3 Jet Lag Treatment Industry Opportunities and Challenges
  4. 2.4 Jet Lag Treatment Industry Restraints
3 Jet Lag Treatment Market by Company
  1. 3.1 Global Jet Lag Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Jet Lag Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Jet Lag Treatment Company Ranking (2024-2026)
  4. 3.4 Global Jet Lag Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Jet Lag Treatment Company Product Type and Application
  6. 3.6 Global Jet Lag Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Jet Lag Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Jet Lag Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Jet Lag Treatment Market by Type
  1. 4.1 Jet Lag Treatment Type Introduction
  2. 4.1.1 Prescription
  3. 4.1.2 OTC
  4. 4.2 Global Jet Lag Treatment Sales Value by Type
  5. 4.2.1 Global Jet Lag Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Jet Lag Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Jet Lag Treatment Sales Value Share by Type (2021-2032)
5 Jet Lag Treatment Market by Application
  1. 5.1 Jet Lag Treatment Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online
  5. 5.2 Global Jet Lag Treatment Sales Value by Application
  6. 5.2.1 Global Jet Lag Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Jet Lag Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Jet Lag Treatment Sales Value Share by Application (2021-2032)
6 Jet Lag Treatment Regional Value Analysis
  1. 6.1 Global Jet Lag Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Jet Lag Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Jet Lag Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Jet Lag Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Jet Lag Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Jet Lag Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Jet Lag Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Jet Lag Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Jet Lag Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Jet Lag Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Jet Lag Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Jet Lag Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Jet Lag Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Jet Lag Treatment Sales Value Share by Country, 2025 VS 2032
7 Jet Lag Treatment Country-level Value Analysis
  1. 7.1 Global Jet Lag Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Jet Lag Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Jet Lag Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Jet Lag Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Jet Lag Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Jet Lag Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Jet Lag Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Jet Lag Treatment Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Jet Lag Treatment Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Nature’s Bounty
  14. 8.3.1 Nature’s Bounty Company Information
  15. 8.3.2 Nature’s Bounty Business Overview
  16. 8.3.3 Nature’s Bounty Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nature’s Bounty Jet Lag Treatment Product Portfolio
  18. 8.3.5 Nature’s Bounty Recent Developments
  19. 8.4 Otsuka Pharma (Pharmavite)
  20. 8.4.1 Otsuka Pharma (Pharmavite) Company Information
  21. 8.4.2 Otsuka Pharma (Pharmavite) Business Overview
  22. 8.4.3 Otsuka Pharma (Pharmavite) Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Otsuka Pharma (Pharmavite) Jet Lag Treatment Product Portfolio
  24. 8.4.5 Otsuka Pharma (Pharmavite) Recent Developments
  25. 8.5 Boiron
  26. 8.5.1 Boiron Company Information
  27. 8.5.2 Boiron Business Overview
  28. 8.5.3 Boiron Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boiron Jet Lag Treatment Product Portfolio
  30. 8.5.5 Boiron Recent Developments
  31. 8.6 Miers Laboratories
  32. 8.6.1 Miers Laboratories Company Information
  33. 8.6.2 Miers Laboratories Business Overview
  34. 8.6.3 Miers Laboratories Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Miers Laboratories Jet Lag Treatment Product Portfolio
  36. 8.6.5 Miers Laboratories Recent Developments
  37. 8.7 Genexa
  38. 8.7.1 Genexa Company Information
  39. 8.7.2 Genexa Business Overview
  40. 8.7.3 Genexa Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genexa Jet Lag Treatment Product Portfolio
  42. 8.7.5 Genexa Recent Developments
  43. 8.8 Homeocan
  44. 8.8.1 Homeocan Company Information
  45. 8.8.2 Homeocan Business Overview
  46. 8.8.3 Homeocan Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Homeocan Jet Lag Treatment Product Portfolio
  48. 8.8.5 Homeocan Recent Developments
  49. 8.9 Clinigen Group
  50. 8.9.1 Clinigen Group Company Information
  51. 8.9.2 Clinigen Group Business Overview
  52. 8.9.3 Clinigen Group Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Clinigen Group Jet Lag Treatment Product Portfolio
  54. 8.9.5 Clinigen Group Recent Developments
  55. 8.10 Vanda Pharma
  56. 8.10.1 Vanda Pharma Company Information
  57. 8.10.2 Vanda Pharma Business Overview
  58. 8.10.3 Vanda Pharma Jet Lag Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vanda Pharma Jet Lag Treatment Product Portfolio
  60. 8.10.5 Vanda Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst